Global pharma major Lupin Limited on Wednesday announced the launch of Varenicline Tablets, 0.5 mg and 1 mg, after having received approval from the United States Food and Drug Administration (U.S. FDA).
Varenicline Tablets, 0.5 mg and 1 mg is the generic equivalent of Chantix Tablets, 0.5 mg and 1 mg, of PF Prism C.V. It is indicated for use as an aid to smoking cessation treatment.
Varenicline Tablets (RLD Chantix) had estimated annual sales of USD 412 million in the U.S. (IQVIA MAT November 2023).